Overview
Dr. Karantanos graduated from the School of Health Sciences at the University of Athens, Greece and received a Ph.D. in cancer biology. He completed a post-doctoral research fellowship in molecular oncology and cancer therapeutics at MD Anderson Cancer Center/University of Texas. He did his internal medicine residency and Chief residency training at Boston University and his medical oncology fellowship training at Johns Hopkins. As a research fellow at Johns Hopkins he studied malignant hematopoiesis and his work led to the identification of CCRL2, as an inducer of MDS/sAML cells growth and a mediator of azacitidine resistance.
Dr. Karantanos is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Splenectomy.
His clinical research consists of co-authoring 90 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Myeloproliferative Neoplasms (MPN).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sidney Kimmel Comprehensive Cancer Center
As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy.
Evan Braunstein is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Braunstein is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Myelofibrosis, Sickle Cell Disease, and Bone Marrow Aspiration. Dr. Braunstein is currently accepting new patients.
Virginia Cancer Specialists, P.C.
Robert Christie is a Hematologist Oncology specialist and a Hematologist in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Multiple Myeloma. Dr. Christie is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Karantanos isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDr. Karantanos isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Karantanos isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Karantanos isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Karantanos isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Karantanos isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Bone Marrow AspirationDr. Karantanos isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Karantanos isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Karantanos isExperienced. Learn about Chronic Myelogenous Leukemia (CML).